Mohamed R. Shaaban, Ahmed H. M. Elwahy, “Bis(α‐bromo ketones): Versatile Precursors for Novel Bis(s‐triazolo[3,4‐b][1,3,4]thiadiazines) and Bis(as‐triazino[3,4‐b][1,3,4]thiadiazines)”, Journal of Heterocyclic Chem, 49, no. 3, 2012, 640
O. V. Gaisenok, “The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis”, Problems of Virology, 65, no. 3, 2020, 167
Irina A. Leneva, Irina N. Falynskova, Nailya R. Makhmudova, Ekaterina A. Glubokova, Nadezhda P. Kartashova, Eugenia I. Leonova, Natalya A. Mikhailova, Irina V. Shestakova, “Effect of triazavirine on the outcome of a lethal influenza infection and secondary bacterial pneumonia following influenza in mice”, Microbiology Independent Research Journal (MIR Journal), 4, no. 1, 2018
O. I. Kiselev, A. V. Vasin, M. P. Shevyryova, E. G. Deeva, K. V. Sivak, V. V. Egorov, V. B. Tsvetkov, A. Yu. Egorov, E. A. Romanovskaya-Romanko, L. A. Stepanova, A. B. Komissarov, L. M. Tsybalova, G. M. Ignatjev, “Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents”, Mol Biol, 49, no. 4, 2015, 480
E. V Sokolova, E. A Hohlacheva, D. D SHamshina, A. E Batychyok, P. A Radaev, N. A Prokof'eva, R. A Litvinov, D. A Babkov, K. V. Savateev, V. V. Fedotov, “ANTIGLYCATION AND DPP-4 INGIBITION ACTIVITY OF NOVEL AZOLEAZINE-DERIVED COMPOUNDS”, Journal of Volgograd State Medical University, 16, no. 1, 2019, 79
Shiu-Wan Chan, “Current and Future Direct-Acting Antivirals Against COVID-19”, Front. Microbiol., 11, 2020, 587944
I. S. Antipin, M. A. Kazymova, M. A. Kuznetsov, A. V. Vasilyev, M. A. Ishchenko, A. A. Kiryushkin, L. M. Kuznetsova, S. V. Makarenko, V. A. Ostrovskii, M. L. Petrov, O. V. Solod, Yu. G. Trishin, I. P. Yakovlev, V. G. Nenaidenko, E. K. Beloglazkina, I. P. Beletskaya, Yu. A. Ustynyuk, P. A. Solov’ev, I. V. Ivanov, E. V. Malina, N. V. Sivova, V. V. Negrebetskii, Yu. I. Baukov, N. A. Pozharskaya, V. F. Traven’, A. E. Shchekotikhin, A. V. Varlamov, T. N. Borisova, Yu. A. Lesina, E. A. Krasnokutskaya, S. I. Rogozhnikov, S. N. Shurov, T. P. Kustova, M. V. Klyuev, O. G. Khelevina, P. A. Stuzhin, A. Yu. Fedorov, A. V. Gushchin, V. A. Dodonov, A. V. Kolobov, V. V. Plakhtinskii, V. Yu. Orlov, A. P. Kriven’ko, O. V. Fedotova, N. V. Pchelintseva, V. N. Charushin, O. N. Chupakhin, Yu. N. Klimochkin, A. Yu. Klimochkina, V. N. Kuryatnikov, Yu. A. Malinovskaya, A. S. Levina, O. E. Zhuravlev, L. I. Voronchikhina, A. S. Fisyuk, A. V. Aksenov, N. A. Aksenov, I. V. Aksenova, “Organic chemistry. History and mutual relations of universities of Russia”, Russ J Org Chem, 53, no. 9, 2017, 1275
Victor V. Fedotov, Vladimir L. Rusinov, Evgeny N. Ulomsky, Evgeny M. Mukhin, Evgeny B. Gorbunov, Oleg N. Chupakhin, “Pyrimido[1,2-a]benzimidazoles: synthesis and perspective of their pharmacological use”, Chem Heterocycl Comp, 57, no. 4, 2021, 383
Ksenia V. Kozhikhova, Maria N. Ivantsova, Maria I. Tokareva, Iliya D. Shulepov, Andrey V. Tretiyakov, Lev V. Shaidarov, Vladimir L. Rusinov, Maxim A. Mironov, “Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin”, Pharmaceutical Development and Technology, 23, no. 4, 2018, 334
Jayanta Dowarah, Brilliant N. Marak, Umesh Chand Singh Yadav, Ved Prakash Singh, “Potential drug development and therapeutic approaches for clinical intervention in COVID-19”, Bioorganic Chemistry, 114, 2021, 105016